Goodwill - ExpreS2ion Biotech Holding AB (STO:EXPRS2)

Watchlist Manager

Watchlist

Price: 14.94 SEK 3.89% Market Closed

Market Cap: kr52.7m

ExpreS2ion Biotech Holding AB
Goodwill

Quarterly

Annual

Adjust for Inflation

Balance Sheet

ExpreS2ion Biotech Holding AB
Goodwill Peer Comparison

Company		Goodwill	CAGR 3Y	CAGR 5Y	CAGR 10Y
E	ExpreS2ion Biotech Holding AB STO:EXPRS2	Goodwill N/A	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years N/A
	Biogaia AB STO:BIOG B	Goodwill kr149.9m	CAGR 3-Years -6%	CAGR 5-Years 95%	CAGR 10-Years N/A
	Bonesupport Holding AB STO:BONEX	Goodwill N/A	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years N/A
	Vitrolife AB STO:VITR	Goodwill kr9.8B	CAGR 3-Years -10%	CAGR 5-Years 88%	CAGR 10-Years 39%
	Swedish Orphan Biovitrum AB (publ) STO:SOBI	Goodwill kr9.2B	CAGR 3-Years 8%	CAGR 5-Years 8%	CAGR 10-Years 19%
	BioArctic AB STO:BIOA B	Goodwill N/A	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years N/A

ExpreS2ion Biotech Holding AB
Glance View

Market Cap

52.7m SEK

Industry

Biotechnology

Expres2ion Biotech Holding AB engages in the development of a portfolio of vaccines for diseases such as COVID-19, influenza, and breast cancer. The company is headquartered in Helsingborg, Skane and currently employs 29 full-time employees. The company went IPO on 2016-07-29. The firm specializes in developing cell lines and processes based on a non-viral Drosophila S2 cells expression system. The firm's ExpreS2 recombinant protein expression platform supports all phases of drug discovery, research and development and manufacturing. ExpreS2 is a non-viral insect cell expression system that establishes stable polyclonal pools that provide high-protein expression levels without selection pressure. The system is designed for transient or stable transfections using vector deoxyribonucleic acid containing a hybrid promoter. The company also ensures high cell density without aggregation or toxic metabolite build-up issues. Through the joint venture AdaptVac ApS, the Company applies a Plug-and-Play Virus Like Particle technology for development of therapeutic and prophylactic vaccines within oncology, infectious diseases and immunological disorders.

View EXPRS2 Analysis

EXPRS2 Intrinsic Value

What is Intrinsic Value?

Economic Moat is a concept popularized by Warren Buffett to describe a company's durable competitive advantage. It represents the 'moat' that protects a company from competitors and helps it sustain profitability over the long term. Our analysis of the past 10 years showed that companies with a wide economic moat significantly outperformed the market, delivering +645% returns compared to +189% for the S&P 500.

Our research into Economic Moat performance spans the past 10 years and focuses on companies with a wide economic moat. For this analysis, we calculated the average stock price returns of these companies, comparing them to the performance of the S&P 500 index over the same period.

The results were compelling: wide moat stocks achieved a remarkable +645% average return, compared to +188% for the broader market. This difference highlights the long-term benefits of investing in businesses that can maintain their market position and pricing power over time.

Note: This research does not account for survivorship bias. Past performance is not indicative of future results.

Determining whether a company has an economic moat requires both a deep dive into financial metrics and a qualitative assessment of its competitive position. Our analysts conduct a rigorous evaluation that focuses on identifying structural advantages that enable a company to sustain profitability and defend its market share over the long term.

The process begins with an analysis of a company’s historical financial performance. We assess how consistently the company has generated returns above its cost of capital and whether those returns have been stable or improving. However, financial performance alone doesn’t reveal the full picture. To understand the sources of these advantages, we evaluate five key drivers of economic moats:

Network Effect: We analyze whether the value of a company’s product or service grows as its user base expands. Platforms like payment systems or marketplaces benefit from this self-reinforcing.

Switching Costs: We assess whether customers face significant costs or disruptions when switching to a competitor’s product or service. High switching costs create customer stickiness and provide pricing power.

Intangible Assets: Strong brands, patents, and regulatory licenses can protect a company’s market position by creating barriers for competitors or enabling premium pricing. For example, a well-recognized consumer brand may command higher customer loyalty and margins.

Efficient scale: Occurs when a market is optimally served by one or a few players, making it unprofitable for new entrants to compete. This typically happens in industries with high fixed costs or geographic constraints, such as utilities or pipelines.

Cost Advantage: Companies with structural cost advantages can produce goods or services at a lower cost than their competitors, enabling them to offer competitive pricing or maintain higher margins. These advantages often arise from economies of scale, superior supply chain management, or proprietary technology. Firms like Walmart leverage their massive scale to negotiate better terms with suppliers, allowing them to undercut competitors on price.

By examining these factors in combination with a company’s financial performance and market positioning, we classify each company into one of three categories:

This rigorous evaluation ensures that our moat ratings are both comprehensive and reliable, giving investors the tools they need to make well-informed, long-term decisions.

The AI Assistant may sometimes provide inaccurate information.

Make your own investment decisions or consult a licensed financial advisor.

ExpreS2ion Biotech Holding AB
STO:EXPRS2

ExpreS2ion Biotech Holding AB
Goodwill

ExpreS2ion Biotech Holding AB
Goodwill Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

ExpreS2ion Biotech Holding AB
Glance View

See Also

Company

Help

Tools

Stocks

ExpreS2ion Biotech Holding AB STO:EXPRS2

ExpreS2ion Biotech Holding AB Goodwill

ExpreS2ion Biotech Holding AB Goodwill Peer Comparison

Competitors Analysis Latest Figures & CAGR of Competitors

ExpreS2ion Biotech Holding AB Glance View

See Also

Company

Help

Tools

Stocks

ExpreS2ion Biotech Holding AB
STO:EXPRS2

ExpreS2ion Biotech Holding AB
Goodwill

ExpreS2ion Biotech Holding AB
Goodwill Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

ExpreS2ion Biotech Holding AB
Glance View